Persistent Underperformance Against Benchmarks
GKB Ophthalmics has been struggling to keep pace with the broader market, as evidenced by its returns relative to the Sensex. Over the past week, the stock declined by 4.20%, while the Sensex gained 0.79%. This divergence has only widened over longer periods, with the stock falling 12.34% in the last month compared to a 0.95% rise in the Sensex. Year-to-date figures reveal a stark contrast: GKB Ophthalmics has plummeted 41.37%, whereas the Sensex has advanced by 9.08%. The one-year and three-year comparisons further highlight the stock’s persistent weakness, with losses exceeding 40% against Sensex gains of over 10% and 39%, respectively. Even over five years, the stock’s modest 9.45% gain pales in comparison to the Sensex’s robu...
Read More













